Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Michael

Showing results (81-90 of 216) with videos related to

Pageof 22
Sort By:
ANZ Journal of Surgery|January 20, 2023
Immunotherapy in colorectal cancer: a beacon of hopeMilton Mui, Joseph C H Kong, Glen R Guerra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Expression and prognostic significance of kit, protein kinase B, and mitogen-activated protein kinase in patients with small cell lung cancerFiona H Blackhall, Melania Pintilie, Michael Michael, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2004
Phase II study of activated charcoal to prevent irinotecan-induced diarrheaMichael Michael, MaryAnne Brittain, Jane Nagai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Antitumor effect of somatostatin analogs in neuroendocrine tumorsYu Jo Chua, Michael Michael, John R Zalcberg, et al.
ANZ Journal of Surgery|January 28, 2019
Outcomes from cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal epithelial neoplasmsVignesh Narasimhan, Toan Pham, Satish Warrier, et al.
Asia-Pacific Journal of Clinical Oncology|March 7, 2023
Impact of neoadjuvant systemic chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal adenocarcinomaMichael P Flood, Georgia Roberts, Catherine Mitchell, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|December 19, 2019
Re-do cytoreductive surgery for peritoneal surface malignancy: Is it worthwhile?Vignesh Narasimhan, Francis Cheung, Peadar Waters, et al.
Clinical Pharmacology and Therapeutics|May 24, 2022
Dihydropyrimidine Dehydrogenase Deficiency and Implementation of Upfront DPYD GenotypingCassandra White, Rodney J Scott, Christine Paul, et al.
Patient Education and Counseling|May 25, 2021
The unmet supportive care needs, quality of life, and care experiences of patients with functioning and non-functioning Neuroendocrine tumours (NETs) at early diagnosisLisa Guccione, Karla Gough, Allison Drosdowsky, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 13, 2017
Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysisSue Ping Thang, Mei Sim Lung, Grace Kong, et al.
Pageof 22

Showing results (81-90 of 216) with videos related to

Sort By:
Pageof 22
ANZ Journal of Surgery|January 20, 2023
Immunotherapy in colorectal cancer: a beacon of hopeMilton Mui, Joseph C H Kong, Glen R Guerra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Expression and prognostic significance of kit, protein kinase B, and mitogen-activated protein kinase in patients with small cell lung cancerFiona H Blackhall, Melania Pintilie, Michael Michael, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2004
Phase II study of activated charcoal to prevent irinotecan-induced diarrheaMichael Michael, MaryAnne Brittain, Jane Nagai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Antitumor effect of somatostatin analogs in neuroendocrine tumorsYu Jo Chua, Michael Michael, John R Zalcberg, et al.
ANZ Journal of Surgery|January 28, 2019
Outcomes from cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal epithelial neoplasmsVignesh Narasimhan, Toan Pham, Satish Warrier, et al.
Asia-Pacific Journal of Clinical Oncology|March 7, 2023
Impact of neoadjuvant systemic chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal adenocarcinomaMichael P Flood, Georgia Roberts, Catherine Mitchell, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|December 19, 2019
Re-do cytoreductive surgery for peritoneal surface malignancy: Is it worthwhile?Vignesh Narasimhan, Francis Cheung, Peadar Waters, et al.
Clinical Pharmacology and Therapeutics|May 24, 2022
Dihydropyrimidine Dehydrogenase Deficiency and Implementation of Upfront DPYD GenotypingCassandra White, Rodney J Scott, Christine Paul, et al.
Patient Education and Counseling|May 25, 2021
The unmet supportive care needs, quality of life, and care experiences of patients with functioning and non-functioning Neuroendocrine tumours (NETs) at early diagnosisLisa Guccione, Karla Gough, Allison Drosdowsky, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 13, 2017
Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysisSue Ping Thang, Mei Sim Lung, Grace Kong, et al.
Pageof 22